Cardioprotection in the Clinical Setting

Author： Ivanes Fabrice   Mewton Nathan   Rioufol Gilles   Piot Christophe   Elbaz Meyer   Revel Didier   Croisille Pierre   Ovize Michel  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.3, 2010-06, pp. : 281-287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardioprotection in the Clinical Setting-Lessons from J-WIND Studies

By Asakura Masanori   Kitakaze Masafumi  

Cardiovascular Drugs and Therapy, Vol. 24, Iss. 3, 2010-06 ,pp. : 289-295

Springer Publishing Company

Access to resources Recommend Favorite

Cardioprotection with Sildenafil: Implications for Clinical Practice

By  

Current Medicinal Chemistry, Vol. 13, Iss. 26, 2006-11 ,pp. : 3155-3164

Bentham Science Publishers

Access to resources Recommend Favorite

Cardioprotection with opioids– Trusted old friends -Clinical Science –

By  

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5794-5798

Bentham Science Publishers

Access to resources Recommend Favorite

Anesthetic Cardioprotection in Clinical Practice From Proof-of-Concept to Clinical Applications

By  

Current Pharmaceutical Design, Vol. 20, Iss. 36, 2014-11 ,pp. : 5706-5726

Bentham Science Publishers

Access to resources Recommend Favorite

Balancing Gastroprotection and Cardioprotection with Selective Cyclo-Oxygenase-2 Inhibitors: Clinical Implications

By Meagher E.A.  

Drug Safety, Vol. 26, Iss. 13, 2003-01 ,pp. : 913-924

Adis International

Access to resources Recommend Favorite